30814 Federal Register / Vol. 72, No. 106 / Monday, June 4, 2007 / Notices 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Dana Jeffrey Plude, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3176, 

MSC 7848, Bethesda, MD 20892, 301–435–

2309, pluded@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts: Cognition, Memory, and Speech 

Therapy. 

Date: July 2, 2007. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Weijia Ni, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 3190, MSC 7848, (for 

overnight mail use room and 20817 zip), 

Bethesda, MD 20892, (301) 435–1507, 

niw@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel ZRG1 ONC–

G (02): Gynecologic Biomarkers. 

Date: July 3, 2007. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: John L. Meyer, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6198, 

MSC 7804, Bethesda, MD 20892, (301) 435–

1213, meyerjl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Food Safety, 

non-HIV Infectious Agents Sterilization and 

Bioremediation. 

Date: July 5–6, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Fouad A. El-Zaatari, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3206, 

MSC 7808, Bethesda, MD 20814–9692, (301) 

435–1149, elzaataf@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Pancreatic 

Islet Biology. 

Date: July 6, 2007. 

Time: 9 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Krish Krishnan, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6164, 

MSC 7892, Bethesda, MD 20892, (301) 435–

1041, krishnak@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2761 Filed 6–01–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Centers for Scientific 

Review Special Emphasis Panel, June 

20, 2007, 12 p.m. to June 20, 2007, 2 

p.m., National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

which was published in the Federal 

Register on May 22, 2007, 72 FR 28706–

28708. 

The meeting will be held June 26, 

2007, from 2 p.m. to 4 p.m. The meeting 

location remains the same. The meeting 

is closed to the public. 

Dated: May 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2762 Filed 6–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Cancer 

Immunopathology and Immunotherapy 

Study Section, June 14, 2007, 8 a.m. to 

June 15, 2007, 5 p.m. The Madison 

Loews Hotel, 1177 15th Street, NW., 

Washington, DC 20005 which was 

published in the Federal Register on 

May 21, 2007, 72 FR 28515–27517. 

The meeting will be held June 14, 

2007, 8 a.m. to 7 p.m. at the Marriott 

Bethesda North Hotel & Conference 

Center, 5701 Marinelli Road, Bethesda, 

MD 20852. The meeting is closed to the 

public. 

Dated: May 25, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2763 Filed 6–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice Regarding Substance Abuse 

and Mental Health Services 

Administration’s National Registry of 

Evidence-Based Programs and 

Practices (NREPP): Priorities for 

NREPP Reviews 

SUMMARY: The Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) is committed to preventing 

the onset and reducing the progression 

of mental illness, substance abuse, and 

substance-related problems among all 

individuals, including youth. As part of 

this effort, SAMHSA has expanded and 

refined the agency’s National Registry of 

Evidence-based Programs and Practices 

(NREPP). Two previous notices 

announcing these changes have been 

published in the Federal Register (70 

FR 50381, Aug. 26, 2005; 71 FR 13133, 

Mar. 14, 2006). A third notice 

announced the first open submission 

period, October 1, 2006, through 

February 1, 2007 (71 FR 37590, June 30, 

2006). 

This notice explains how SAMHSA 

and its three Centers will prioritize 

interventions submitted for NREPP 

reviews during fiscal year 2008 and 

provides guidance on the submission 

process. This information can be helpful 

to individuals and organizations seeking 

to have an intervention reviewed and 

described on the NREPP Web site. 

FOR FURTHER INFORMATION CONTACT: 

Kevin D. Hennessy, PhD, Science to 

Service Coordinator/SAMHSA, 1 Choke 

Cherry Road, Room 8–1017, Rockville, 

MD 20857, (240) 276–2234. 

Dated: May 25, 2007. 

Terry L. Cline, 

Administrator, SAMHAS. 

Substance Abuse and Mental Health 

Services Administration’s National 

Registry of Evidence-Based Programs 

and Practices (NREPP): Priorities for 

NREPP Reviews 

Background 

The Substance Abuse and Mental 

Health Services Administration’s 

(SAMHSA) National Registry of 

Evidence-based Programs and Practices 


rwilkins on PROD1PC63 with NOTICES
Federal Register / Vol. 72, No. 106 / Monday, June 4, 2007 / Notices 30815 

(NREPP) is a voluntary rating system 

designed to provide the public with 

reliable information on the scientific 

basis and practicality of interventions 

that prevent and/or treat mental health 

and substance use disorders. Descriptive 

information and quantitative ratings are 

provided across several key areas for all 

interventions reviewed by NREPP. This 

information is available to the public 

through a new NREPP Web site 

(http://www.nrepp.samhsa.gov). 

Public input from a range of 

stakeholders has improved NREPP’s 

accessibility and usefulness as a 

‘‘decision support tool’’ to help States, 

Territories, community-based 

organizations, and other interested 

stakeholders identify interventions that 

may meet their needs. NREPP provides 

useful information—including ratings 

on the quality of research and readiness 

for dissemination—to assist individuals 

and organizations in identifying 

interventions that may address their 

particular needs and match their 

specific capacities and resources. 

Each of SAMHSA’s Centers—the 

Center for Substance Abuse Prevention, 

the Center for Substance Abuse 

Treatment, and the Center for Mental 

Health Services—has established annual 

review priorities regarding the types of 

interventions to be included in NREPP. 

In general, these priorities represent the 

interests and needs of relevant 

stakeholders and reflect SAMHSA’s 

matrix and grant priorities. 

This notice describes the Centers’

priorities for fiscal year 2008 and 

provides guidance to individuals and 

organizations who may be considering 

submitting an intervention for NREPP 

review. 

SAMHSA’s NREPP Priorities 

SAMHSA is prioritizing for NREPP 

review interventions that prevent and 

treat mental and/or substance use 

disorders. For NREPP purposes, 

SAMHSA defines interventions as 

programs, practices, and/or 

environmental strategies designed to 

change behavioral outcomes among a 

definable population or within a 

definable geographic area. 

Minimum Requirements for NREPP 

Review 

Individuals and organizations 

interested in submitting an intervention 

for review must first document that the 

intervention meets the following three 

requirements: 

1. The intervention demonstrates one 

or more positive outcomes (p ≤ .05) in 

mental health and/or substance use 

behavior among individuals, 

communities, or populations. 

2. Intervention results have been 

published in a peer-reviewed 

publication or documented in a 

comprehensive evaluation report. 

3. Documentation (e.g., manuals, 

process guides, tools, training materials) 

of the intervention and its proper 

implementation is available to the 

public to facilitate dissemination. 

Interventions that do not meet all 

three of these minimum requirements 

will not be considered for NREPP 

review. 

SAMHSA particularly encourages 

submissions of gender and culturally 

appropriate interventions that 

specifically target the following 

underserved populations: American 

Indian/Alaska Native, Asian American, 

Black or African American, Hispanic or 

Latino, and Native Hawaiian or other 

Pacific Islander. 

Priority Review Points 

Interventions that meet the three 

minimum requirements may be awarded 

points that will help determine their 

prioritization for potential NREPP 

review. Interventions will receive 1 

priority point, and thus higher priority 

for potential NREPP review, if they have 

been evaluated using a quasiexperimental or experimental study 

design. Such studies may include a pre/ 

post design with a comparison or 

control group or a longitudinal/time 

series design. Time series designs must 

include at least three preintervention or 

baseline measurements and at least 

three postintervention or follow-up 

measurements. An additional priority 

point may be obtained if at least one 

primary outcome of the submitted 

intervention falls within any of the 

current SAMHSA Center Priority Areas. 

The Priority Areas for fiscal year 2008 

for each of SAMHSA’s three Cnters are 

listed below. 

Center for Substance Abuse Prevention 

(CSAP) 

CSAP strives to expand and enhance 

the development of comprehensive, 

integrated systems and services within 

all States, Tribes, and jurisdictions that 

promote community and personal 

health and wellness and prevent 

substance abuse and mental disorders. 

In support of this goal, CSAP Priority 

Areas focus on comprehensive 

community-based approaches and 

innovative interventions that: 

• Prevent and/or reduce substance 

abuse and its related problems—e.g., 

underage drinking, inhalant abuse, 

cannabis use and abuse, drug-related 

suicide, alcohol and drug abuse among 

young adults, misuse of alcohol and 

prescription drugs among the elderly, 

and HIV/substance abuse problems. 

• Reduce risk factors and/or increase 

protective factors (factors known to 

contribute to positive changes in 

substance abuse behaviors). 

• Address emerging substance abuse 

problems—e.g., methamphetamine use, 

abuse of over-the-counter and 

prescription drugs, use of fentanyl and 

other synthetic drugs. 

Center for Substance Abuse Treatment 

(CSAT) 

CSAT Priority Areas focus on 

interventions to treat adolescents and 

adults with alcohol and/or drug 

disorders, including interventions 

developed or adapted for special 

populations (e.g., American Indians/ 

Alaska Natives, other minorities), that 

are delivered as part of one or more of 

the following types of services: 

• Screening and brief intervention in 

general health care settings. 

• Outreach and engagement for drugdependent populations, including 

persons with or at risk for HIV. 

• Treatment and rehabilitation, 

including behavioral interventions 

alone or in combination with 

pharmacological treatment. 

• Treatment and rehabilitation for 

individuals involved in the criminal 

justice system. 

• Recovery support and/or continuing 

care. 

Center for Mental Health Services 

(CMHS) 

CMHS Priority Areas focus on 

interventions to: 

• Foster consumer- and familyprovided mental health services, 

excluding school-based services. 

• Reduce the effects of trauma on the 

mental well-being of children, 

adolescents, and adults. 

• Promote employment among 

individuals with serious mental illness. 

• Provide treatment for mental 

illnesses in settings that are either 

integrated or closely coordinated with 

primary care. 

• Divert adults with serious mental 

illness and/or children and adolescents 

with serious emotional disturbances 

from criminal and juvenile justice 

systems. 

• Develop alternatives to the use of 

seclusion and restraint for adults with 

serious mental illness and/or children 

and adolescents with serious emotional 

disturbances. 

• Prevent suicide in specific age 

groups (i.e., adolescents, young adults, 

elders). 


rwilkins on PROD1PC63 with NOTICES
30816 Federal Register / Vol. 72, No. 106 / Monday, June 4, 2007 / Notices 

Exclusions From NREPP 

The following types of interventions 

are not eligible for review and should 

not be submitted to NREPP: 

1. Stand-alone pharmacologic 

treatments—The evidence base for 

pharmacologic treatments is reviewed 

and approved through the U.S. Food 

and Drug Administration (FDA). NREPP 

reviews will be limited to on-label use 

of FDA-approved pharmacotherapy 

interventions that are combined with 

one or more psychosocial treatments. 

2. Stand-along smoking prevention 

and/or cessation interventions—These 

interventions are appropriate for NREPP 

review only when they are conducted as 

part of a program addressing the 

prevention and/or treatment of alcohol 

or other drugs of abuse. 

Availability of NREPP Review Funds 

The number of reviews conducted by 

NREPP in any given year is contingent 

on both the total number of submissions 

received and the availability of NREPP 

contract resources. SAMHSA cannot 

guarantee the review of any specific 

submission. 

Submission Guidance 

SAMHSA has established a 4-month 

period for receipt of NREPP submissions 

in fiscal year 2008 that will begin 

October 1, 2007, and end February 1, 

2008. Interventions submitted after 

February 1, 2008, will not be considered 

for NREPP review during this fiscal 

year. Interventions not selected for 

review may be resubmitted again in the 

next open submission period provided 

they meet NREPP’s minimum 

requirements. All submissions must be 

made by the intervention developer or 

principal investigator. Third parties may 

submit an intervention, but 

documentation must be provided to 

NREPP confirming that the intervention 

developer or principal investigator has 

formally authorized the third-party 

submission. 

To be considered for potential review, 

interventions must demonstrate that 

they meet NREPP’s three minimum 

requirements. Table 1 depicts the types 

of documentation that should be 

submitted so that NREPP staff can 

accurately assess whether the 

intervention meets these requirements. 

If an intervention is accepted for 

review, additional supporting 

documentation and three copies of all 

hard-copy dissemination materials will 

need to be submitted. 

TABLE 1.—SUGGESTED DOCUMENTATION INDICATING COMPLIANCE WITH MINIMUM REQUIREMENTS

Minimum requirement Suggested supporting documentation 

1. The intervention demonstrates one or more positive outcomes (p ≤ 

.05) related to mental health and/or substance use behaviors.

Full-text electronic or hard copies of: 

• Research articles. 

• Published and/or unpublished evaluation reports. 

• Grant final reports. 

• Replication studies. 

Note: Abstracts or URLs to partial articles are regarded as incomplete 

and will not be considered. 

2. Intervention results have been published in a peer-reviewed publication or documented in a comprehensive evaluation report. A comprehensive evaluation report has the following components: Review 

of the literature, theoretical framework, purpose, methodology, findings/results, discussion, and conclusions.

3. Documentation of the intervention and its implementation is available 

to the public to facilitate dissemination.

• List of dissemination materials (e.g., manuals, process guides, tools, 

training materials, quality assurance protocols) that are available to 

the public. 

• Materials catalog. 

• Program Web site. 

Selection and Ordering of Reviews 

All submitted interventions meeting 

NREPP’s minimum requirements will be 

considered for NREPP review. The 

selection of interventions and order of 

reviews will be determined in part by a 

system of priority points on the 

SAMHSA Center Priority Areas 

described above. Interventions awarded 

2 priority points have higher priority 

than those awarded 1 priority point, and 

interventions awarded 1 priority point 

have higher priority than those awarded 

0 priority points. In addition, SAMHSA 

reserves the right to select interventions 

based on other factors to ensure that 

NREPP provides a balanced portfolio of 

information relating to the prevention 

and/or treatment of mental health and/ 

or substance use disorders. 

NREPP submissions not selected for 

review will be returned to the applicant. 

These submissions will not 

automatically be considered for review 

in subsequent submission cycles; 

however, applicants may choose to 

resubmit their intervention at a later 

date. 

The number of reviews that NREPP 

actually undertakes in any given year 

will depend upon available contract 

resources. 

Contact Regarding Submissions 

Individuals and organizations 

interested in submitting an intervention 

should contact the NREPP contractor, 

MANILA Consulting Group, to express 

their interest. Staff from MANILA will 

provide further guidance and details 

about the submission process as 

appropriate. Electronic correspondence 

(e-mail) is preferred and can be sent to 

nrepp@samhsa.hhs.gov. Interested 

parties can also contact MANILA by 

phone at (571) 633–9797, ext. 406. 

[FR Doc. 07–2739 Filed 6–1–07; 8:45 am] 

BILLING CODE 4160–01–M 

DEPARTMENT OF THE INTERIOR 

Office of the Secretary 

Privacy Act of 1974, as Amended; 

Addition of a New System of Records 

AGENCY: Department of the Interior, 

Office of the Secretary. 

ACTION: Proposed addition of a new 

system of records. 

SUMMARY: The Department of the 

Interior (DOI) is issuing public notice of 

its intent to add a new Privacy Act 

system of records to its inventory of 

records systems subject to the Privacy 

Act of 1974 (5 U.S.C. 552a). The Privacy 

Act requires publication of a Federal 

Register notice of the existence and 

character of records systems maintained 

by the agency (5 U.S.C. 552 a e)(4)). The 

new system of records is ‘‘DOI–06’’ and 

is titled ‘‘The ‘America The Beautiful—

The National Parks and Federal 


rwilkins on PROD1PC63 with NOTICES